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activity of NADPH oxidase in response to various stimuli. Here, we describe that Ang II induced both Rac2 translocation
from the cytosol to the plasma membrane and Rac2 GTP-binding activity. Furthermore, Clostridium difficile toxin A, an
inhibitor of the Rho-GTPases family Rho, Rac and Cdc42, prevented Ang II-elicited OK2 =ROS production, phosphorylation
of the mitogen-activated protein kinases (MAPKs) p38, extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-
terminal kinase 1/2, and Rac2 activation. Rac2 GTPase inhibition by C. difficile toxin A was accompanied by a robust
reduction of the cytosolic Ca2C elevation induced by Ang II in human neutrophils. Furthermore, SB203580 and
PD098059 act as inhibitors of p38MAPK and ERK1/2 respectively, wortmannin, an inhibitor of phosphatidylinositol-3-
kinase, and cyclosporin A, a calcineurin inhibitor, hindered both translocation of Rac2 from the cytosol to the plasma
membrane and enhancement of Rac2 GTP-binding elicited by Ang II. These results provide evidence that the activation
of Rac2 by Ang II is exerted through multiple signalling pathways, involving Ca2C/calcineurin and protein kinases, the
elucidation of which should be insightful in the design of new therapies aimed at reversing the inflammation of vessel walls
found in a number of cardiovascular diseases.Journal of Molecular Endocrinology (2007) 39, 351–363Introduction
Angiotensin II (Ang II), the main peptide hormone of
the renin–angiotensin system, induces leukocyte
recruitment to the vessel wall, which constitutes a
hallmark of early stages of atherosclerosis and several
hypertensive diseases (Ross 1999). Ang II acts via high-
affinity cell surface receptors (AT1), which are linked to
pathways classically associated with G-protein-coupled
and tyrosine kinase-mediated responses (Timmermans
et al. 1993). Although most studies on Ang II have been
carried out on smooth muscle and endothelial cells,
experimental evidence has also been obtained of its
effects on circulating cells. Expression of AT1 receptors
for Ang II has been evidenced in circulating neutro-
phils (Ito et al. 2001) and in human peripheral
monocytes (Shimada & Yakazi 1978), and Ang
II-induced monocyte activation has been reportedJournal of Molecular Endocrinology (2007) 39, 351–363
0952–5041/07/039–351 q 2007 Society for Endocrinology Printed in Great Britain(Hahn et al. 1994). In this context, the adhesion of
leukocytes to endothelial cells is a primary event taking
place during the pathogenesis of vascular diseases
(Mazzone et al. 1993).
Given that chronic inflammation of vessel walls is a
pathological indicator of hypertension (Touyz 2003)
and that reactive oxygen species (ROS) such as
superoxide anion ðOK2 Þ and H2O2 constitute the main
intermediary molecules responsible for inflammation
(Finkel 1998), a link between the development of
hypertension and ROS production has been postulated
(El Bekay et al. 2003). NADPH oxidase in phagocytic
cells is a multi-component enzyme composed of at least
two membrane proteins, gp91phox and p22phox, which
together form the flavocytochrome b558, and four
cytosolic proteins, namely p47phox, p67phox, p40phox
and Rac. In resting cells, this oxidase is inactive and its
components are distributed separately between the cellDOI: 10.1677/JME-07-0074
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exposed to appropriate stimuli, NADPH oxidase
becomes activated through the association of all its
components at the plasma membrane, which is
followed by OK2 production (Inanami et al. 1998a,b,
2001, Johnson et al. 1998, Babior 2000).
The Rac small GTPases, members of the Rho-GTPases
family, including Rho, Cdc42 and Rac, constitute a
growing subgroup of Ras proteins which act as molecular
switches upon their cycling between active GTP- and
inactive GDP-bound states (Van Aelst & D’Souza-Schorey
1997). Previous studies have shown that Rho-GTPases are
involved in multiple cellular processes, such as actin
polymerization and cytoskeleton rearrangement,
regulation of gene transcription, cell cycle progression
and cell survival (Etienne-Manneville & Hall 2002). The
Rac subfamily of Rho-GTPases includes three highly
homologous members, namely Rac1, Rac2 and Rac3.
Unlike Rac1 and Rac3, which are widely expressed, Rac2 is
found only in haematopoietic cells (Didsbury et al. 1989,
Haataja et al. 1997) In addition to their reported roles in
actin remodelling, Rac proteins have been implicated in
the generation of OK2 via the phagocytic NADPH oxidase
complex (Segal & Abo 1993). Rac1 was identified as an
oxidase-related factor from peritoneal macrophages
(Abo et al. 1991), whereas Rac2 was demonstrated to
fulfil such a role in human neutrophils (Knaus et al. 1991,
Bokoch 1994). Rac exists in the cytosol as a complex with a
GDP dissociation inhibitor (Abo et al. 1991), and upon
activation of NADPH oxidase Rac separates from this
inhibitor and becomes stably associated with NADPH
oxidase components at the plasma membrane (Northup
et al. 1982, Curnutte et al. 1987). The GTP-bound form of
Rac binds to p67phox, and also likely to flavocytochrome
b558, in the assembled active oxidase complex (Diek-
mann et al. 1994, Heyworth et al. 1994, Koga et al. 1999).
In a cell-free system, Rac1 and Rac2 recombinant
proteins can reconstitute a fully active NADPH oxidase
complex able to produce OK2 (Abo et al. 1991, 1992,
Knaus et al. 1991). Moreover, it has recently been
reported that neutrophils from Rac2-deficient mice
exhibit a diminished NADPH oxidase activity (Roberts
et al. 1999, Ambruso et al. 2000, Williams et al. 2000, Kim
& Dinauer 2001). This finding is consistent with other
previous results suggesting that Rac2 is a primary
GTPase modulator of NADPH oxidase activation
(Heyworth et al. 1994). However, upstream signals and
regulatory proteins controlling Rac activity in neutro-
phils remain unknown, and only an involvement of
phosphatidylinositol-3-kinase (PI3K) in Rac2 activation
elicited by the respiratory burst stimulator, N-formyl-L-
methionyl-L-leucyl-L-phenylalanine (fMLP), has been
demonstrated so far (Akasaki et al. 1999, Benard et al.
1999). Therefore, the role of Rac2 in Ang II-stimulated
neutrophils remains to be analysed.Journal of Molecular Endocrinology (2007) 39, 351–363Recently, the mitogen-activated protein kinases
(MAPKs) family has become a focus of interest in
cardiovascular research. In human neutrophils, we have
described that Ang II induces a robust phosphorylation
of p38MAPK, extracellular signal-regulated kinase 1/2
(ERK1/2) and c-Jun N-terminal kinase 1/2 (JNK1/2),
which is hindered by inhibitors of NADPH oxidase and
tyrosine kinases, as well as by ROS scavengers (El Bekay
et al. 2003). Also, we have reported that Ang II enhances
the synthesis de novo and activity of calcineurin (CaN)
and that the immunosuppressant cyclosporin A (CsA)
inhibits Ang II-induced CaN activity, but not CaN
synthesis (El Bekay et al. 2003). In this study, we present
experimental evidence that Ang II promotes Rac2
translocation from the cytosol to the plasma membrane
in human neutrophils. Conversely, prevention of Rac2
translocation by Clostridium difficile toxin A, an inhibitor
of Rho-GTPases, including Rho, Rac and Cdc42
(Aktories et al. 2000, Voth & Ballard 2005), abolishes
ROS production and activation of p38MAPK, ERK1/2
and JNK1/2 elicited by Ang II in human neutrophils.
The present data thus indicate that Rac2 translocation to
the plasma membrane plays a critical role in Ang
II-dependent signalling pathways in human neutrophils.Materials and methods
Chemicals and reagents
Ang II, SP6000125 and chemicals of general use were
purchased from Sigma–Aldrich or Calbiochem and
eprosartan was from Solvay Pharma. The rabbit polyclonal
antibodies to phosphorylated p38MAPK (Thr180/Tyr182)
and total p38MAPK, and mouse monoclonal antibodies to
phosphorylated ERK1/2 (Thr202/Tyr204) and total
ERK1/2 were obtained from New England Biolabs
(Beverly, MA, USA). Mouse antibodies from Santa Cruz
Biotechnology (Santa Cruz, CA, USA) to phosphorylated
JNK1/2 (Thr183/Tyr185) and total JNK1/2 (sc-6254 and
sc-571 respectively), and rabbit antibodies to Rac2 (sc-96)
and b-actin (sc-7210) were also used. Goat polyclonal
antibodies against p22phox were kindly donated by T L
Leto (NIH, Bethesda, MD, USA). The p21-activated
kinase-1 p21-binding domain (PAK-1 PBD) conjugated
to agarose, GTPgS and GDP were products from Upstate
Cell Signaling. The inhibitors PD089059, SB203580
and NSC23766 were obtained from Calbiochem. The
rabbit antiserum against CaN was kindly provided by Dr C
B Klee (NIH).Human neutrophil extraction and processing
Human peripheral neutrophils were obtained from
healthy blood donors and processed as described in
Carballo et al. (1999). Neutrophils were suspended in
KR-HEPES buffer and subjected for 30–60 min at 37 8Cwww.endocrinology-journals.org
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except for the experiments shown in Figs 5 and 7, in
which the cells were preincubated at 37 8C for 7 h in
Krebs Ringer (KR)-HEPES before additions. Under
these conditions, cell viability ranged between 90 and
97%, as estimated from the lactic dehydrogenase
release assay (Gualberto et al. 1998). The Universidad
de Sevilla Ethics Committee approved this study and
each subject gave informed consent prior to its
undertaking.Figure 1 Angiotensin II stimulates Rac2 translocation from the
cytosol to the plasma membrane in an AT1 receptor-dependent
manner in human neutrophils. Neutrophils were suspended in
KR-HEPES buffer at 107 cells/ml and incubated for 10 min at
37 8C with Ang II at the indicated concentrations (A), with or
without 10 nM Ang II for different times (B), or else previously
incubated in the absence or presence of 10 ng/ml eprosartan
(Epro) for 30 min and then treated or not with 10 nM Ang II for
10 min (C). The cells were then lysed, and the plasmamembrane-
enriched fraction was separated from the cytosolic fraction by
ultracentrifugation at 100 000 g. Membrane (mb) (A–C) and
cytosolic (cyt) proteins (A) were subjected to SDS-PAGE
(50 mg/lane), transferred to PVDF membranes and probed with
antibodies against Rac2. Each blot is representative of a set of
three experiments yielding similar results, and values given within
parentheses correspond to Rac2 membrane levels normalized to
those found in the absence of Ang II stimulation (meanGS.E.M.
from three separate experiments). Statistically significant
*P!0.01. p22phox membrane levels are also shown for the sake of
loading controls. In separate experiments, cells incubated in the
absence (a and b) or presence (c and d) of 10 nM Ang II for 10 min
were fixed onto poly-L-lysine-coated slides and probed with
antibodies against Rac2 and FITC-conjugated anti-rabbit IgG (D).
Immunostained cells were observed under a Nikon EFD-3 light
microscope. Pictures of the same, representative fields taken
under fluorescent (a and c) and bright-field (b and d) microscopy
conditions are shown.Mobilization of Rac2
Human neutrophils (107 cells) were lysed on ice for
30 min in 60 ml buffer containing 100 mM HEPES
(pH 7.3), 100 mM KCl, 3 mM NaCl, 3 mM MgCl2,
1.25 mM EGTA, and the protease inhibitors phenyl-
methylsulphonyl fluoride (1 mM), aprotinin
(20 mg/ml), leupeptin (20 mg/ml) and benzamidine
(156 mg/ml). Then, the cells were disrupted by
sonication (20 W, three bursts of 5 sec each separated
by 30-s interval), and unbroken cells and debris were
removed by centrifugation at 10 000 g for 5 min at 4 8C.
The supernatant obtained after further ultracentrifuga-
tion at 100 000 g for 30 min at 4 8C constituted the
cytosolic fraction. The pellet was resuspended in a
buffer containing 120 mM NaH2PO4 (pH 7.4), 1 mM
MgCl2, 1 mM EGTA, 1 mM dithiothreitol, 20% (v/v)
glycerol, 40 mM octylglucoside and the protease
inhibitors as indicated above, and then recentrifuged
at 20 000 g for 40 min at 4 8C. The new supernatant
obtained, containing solubilized membranes, was used
for immunoblotting analysis of Rac2 mobilization
(El Bekay et al. 2003). With this purpose, this fraction
was subjected to SDS-PAGE on 10% polyacrylamide gels
(50 mg protein/lane) and electroblotted onto polyviny-
lidene difluoride membranes using a semi-dry device
(Bio-Rad). Thereafter, antibody probing was carried out
overnight without need of prior blocking (Mansfield
1995) with rabbit anti-Rac2 IgG, at a 1:2000 dilution in
PBS supplemented with 0.02% Tween 20 and 1% BSA,
and the 21.429 kDa Rac2 band (Didsbury et al. 1989)
was detected by incubation with horseradish peroxidase
(HRP)-conjugated anti-rabbit IgG at a 1:20 000 dilution
in PBS with 0.5% (w/v) BSA, followed by enhanced
chemiluminescence as previously indicated (Carballo
et al. 1999). Briefly, the membranes were incubated for
1 min in 10 ml fresh luminescent reagent solution,
composed 10 mM Tris–HCl (pH 8.5), 2.25 mM lumi-
nol, 0.015% (v/v) H2O2 and 0.45 mM 4-iodophenol,
the latter acting as an enhancer of the chemi-
luminescence reaction, and the signals were recorded
on X-ray-sensitive films. The membrane levels of the
p22phox subunit of NADPH oxidase were monitored as a
loading control, as previously described (Mankelow &
Henderson 2001).www.endocrinology-journals.org Journal of Molecular Endocrinology (2007) 39, 351–363
Figure 2 Cyclosporin A inhibits Rac2 translocation to the plasma
membrane in angiotensin II-stimulated neutrophils. Neutrophils
(107 cells/ml) were preincubated for 1 h at 37 8C in the absence or
presence of 1 mg/ml CsA, and then treated with Ang II for 10 min at
the indicated doses (A), or else they were preincubated with
different concentrations of CsA for 1 h, and then treated or not with
10 nM Ang II for further 10 min at 37 8C (B). The cells were then
lysed, and the plasma membrane-enriched fraction was analysed
by immunoblotting with antibodies against Rac2. Each blot is
representative of a set of four experiments yielding similar results.
Values given within parentheses correspond to Rac2 membrane
levels normalized to those found in the absence of CsA and Ang II
treatment (meanGS.E.M. from three separate experiments).
Statistically significant *P!0.01. p22phox membrane levels are
also shown for the sake of loading controls.
Figure 3 SB203580, PD098059, SP600125 and wortmannin
inhibit angiotensin II-dependent Rac2 translocation to the plasma
membrane in human neutrophils. Neutrophils (107 cells/ml) were
preincubated for 30 min at 37 8C in the absence or presence of
5 mM SB203580 or 5 mM PD098059 (A), 1 mM SP600125 (B), or
10–100 nM wortmannin (Wort) (C), and then treated or not for
10 min with 10–100 nM Ang II. Rac2 membrane levels were
analysed by immunoblotting. Each blot is representative of a
set of four experiments yielding similar results, and values given
within parentheses correspond to Rac2 membrane levels
normalized to those found in the absence of treatments
(meanGS.E.M. from three separate experiments). Statistically
significant *P!0.01. p22phox membrane levels are shown
for the sake of loading controls.
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Rac2 activity pull-down assays were carried out essentially
as described previously (Price et al. 2003), on the basis of
the capacity of PAK proteins to bind to GTP-activated
Rac2, but not to Rac2 bound to GDP. After the treatments
indicated in each case, neutrophils (107 cells) were
washed and then lysed in a magnesium-containing lysis
buffer composed 25 mM HEPES (pH 7.5), 150 mM NaCl,
10 mM MgCl2, 25 mM NaF, 1 mM EDTA, 1 mM Na3VO4,
1% (v/v) Nonidet P-40, 2% (v/v) glycerol, 100 mM
phenylarsine oxide and the protease inhibitors described
above. After centrifugation at 15 000 g, the supernatant
obtained was incubated with 5–10 mg PAK-1 PBD agarose
beads, and the reaction mixture was gently rocked at 4 8C
for 1 h. In parallel, lysates from untreated neutrophils
were loaded with 100 mM GTPgS (positive control) or
1 mM GDP (negative control), for 15 min at 30 8C before
addition of PAK-1 PBD agarose. The beads were then
pelleted and washed, and immunoblotting analysis was
carried out with anti-Rac2 antibodies as described above.p38MAPK, ERK1/2 and JNK1/2 phosphorylation
In order to reduce the MAPK basal phosphorylation levels
usually found in our preparations of human neutrophils,
these cells were preincubated in KR-HEPES at 37 8C forJournal of Molecular Endocrinology (2007) 39, 351–3637 h. After the treatments indicated in each case, the
cells were lysed and immunoblotting analysis with
antibodies to phosphorylated and total forms of the
three MAPKs was carried out as described (El Bekay et al.
2003). Relative protein levels were determined by
scanning densitometry analysis using the Scion Image
software (Frederick, MD, USA).OK2 and total ROS production
The production of ROS was analysed by two separate
methods, each with a different specificity for the location
and type(s) of ROS produced. (i) The lucigenin-based
luminescence method was specific for OK2 , whereas (ii)
luminol-based luminescence correlated well with total
ROS produced by the cells (Li et al. 1998). Since bothwww.endocrinology-journals.org
Figure 4 Angiotensin II enhances Rac2 GTP-binding activity in an
AT1 receptor-dependentmanner inhumanneutrophils. Involvement
of p38MAPK, ERK1/2, PI3K and CaN. Neutrophils (107 cells/ml)
were preincubated at 37 8C for 30 min in the absence or presence of
either 10 ng/ml eprosartan (Epro) (A), 5 mM PD098059 or 5 mM
SB203580 (B), 100 nM wortmannin (Wort) or 10 ng/ml C. difficile
toxin A (Tox A) (C), or else they were preincubated for 1 h with or
without 1 mg/ml CsA (D). Then the cells were stimulated with 10 nM
Ang II for 10 min or with 10 nM fMLP for 3 min at 37 8C, where
indicated. Rac2 GTP-binding activity was measured by PAK-1
PBD affinity precipitation followed by Rac2 immunoblotting analysis
as described in Materials and methods. Lysates from untreated
neutrophils loaded with 100 mMGTPgS or 1 mM GDP prior to pull-
down assays are shown as positive and negative controls
respectively. Each blot is representative of a set of three
experiments yielding similar results, and values given within
parentheses correspond to GTP-bound Rac2 levels normalized to
those found in the absence of treatments (meanGS.E.M. from three
separate experiments). Statistically significant *P!0.01.
Figure 5 Cyclosporin A inhibits p38MAPK, ERK1/2 and JNK1/2
activation in angiotensin II-stimulated human neutrophils.
(A) Neutrophils (107 cells/ml) were preincubated for 7 h at 37 8C in
KR-HEPESwithout additions. Then, they were incubated for 1 h in
the absence or presence of 1 mg/ml CsA, and thereafter for 10 min
with 10 nM Ang II, and the levels of phosphorylated ERK1/2 and
p38MAPK together with total levels of p38MAPK were analysed
by immunoblotting. (B) Idem as in panel A, except that cells were
treated or not with different concentrations of Ang II, and the levels
of phosphorylated and total JNK1/2 were analysed by immuno-
blotting. Each blot is representative of a set of four experiments
yielding similar results, and values given within parentheses
correspond to levels of phosphorylated MAPKs normalized to
those found in the absence of treatments (meanGS.E.M. from
three separate experiments). Statistically significant *P!0.01.
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the cell membrane, their luminescence was an indi-
cation of the sum of intracellular plus extracellular ROS.
The assays were carried out as described previously
(Monteseirı´n et al. 1996), except that HRP (8 mU/ml)
was included when luminol was used.Calcineurin protein and phosphatase activity levels
CaN phosphatase activity was measured as previously
described (El Bekay et al. 2003). For immunoblottingwww.endocrinology-journals.organalysis of CaN subunits A and B, neutrophils were
lysed and subjected to SDS-PAGE (50 mg protein/lane)
as described earlier (El Bekay et al. 2003). Detection
was carried out by enhanced chemiluminescence as
indicated above. To verify even protein loading, the
blots were subsequently stripped and reprobed with
rabbit polyclonal antibodies against b-actin at a 1:1000
dilution.Immunofluorescence microscopy analysis of Rac2
membrane translocation
The membrane translocation of Rac2 in human
neutrophils was also assessed by immunofluorescence
cell staining, as described previously (Vega et al. 2004)
with minor modifications. After stimulation, neutro-
phils (107 cells) were harvested, washed with PBS and
smeared onto poly-L-lysine-coated glass slides. The cells
were fixed at room temperature with 2% paraformalde-
hyde for 30 min. After washing with PBS, unspecific
binding was blocked with PBS containing 0.2% gelatin.
Further, the cells were permeabilized with 0.1% Triton
X-100 for 4 min, and thereafter incubated with rabbit
anti-Rac2 IgG at a 1:100 dilution for 30 min, washedJournal of Molecular Endocrinology (2007) 39, 351–363
Table 1 Clostridium difficile toxin A prevents OK2 /ROS





Ang II (10 nM) 0.240*G0.030 0.450*G0.048
Ang II (10 nM)CTox A
(5 ng/ml)
0.073G0.005 0.142G0.021
Ang II (10 nM)CTox A
(10 ng/ml)
0.046G0.012 0.012G0.001
Neutrophils (106 cells/ml) were incubated for 30 min in the absence or
presence of toxin A from C. difficile (Tox A) at the indicated concentrations.
Then5 pMlucigeninor luminolwereadded for themeasurementofOK2 orROS
production respectively, and the reaction was started with Ang II addition.
Values obtained (relative units/10 min!106 cells) are given themeanGS.E.M.
of three separate experiments. Statistically significant *P!0.01.
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rabbit IgG at a 1:500 dilution for 30 min. After final
washing, coverslips were mounted on the slides using
50% glycerol in PBS. Immunostained cells were
observed and photographed using a Nikon EFD-3
microscope.
Intracellular Ca2C levels
Cytosolic [Ca2C] was measured in cell populations
using the fluorescent probe Fura2 as described
previously (Sage et al. 1990).
Statistical analysis
Data are expressed as the meanGS.E.M. from a
minimum number of three independent experiments.
Protein expression levels were determined by densito-
metry of the bands using Scion Image software. This
software detects the bands obtained by western blot and
gives individual values which are dependent on the
light quantification of the corresponding band.
Measurements are expressed as arbitrary units. The
results were normalized for unstimulated control. The
numerical data obtained from Ang II stimulated and
the corresponding controls were statistically analysed
using Statgraphics plus 5.0 software (Manugistic Inc.,
Rockville, MD, USA) from ANOVA and the paired t-test.
Asterisks indicate P values !0.01.Results
Ang II promoted Rac2 translocation from the cytosol
to the plasma membrane in human neutrophils
Ang II exogenously added promoted the accumulation
of Rac2 at the plasma membrane in humanJournal of Molecular Endocrinology (2007) 39, 351–363neutrophils, with maximal levels being reached at a
10 nM concentration of Ang II and with concomitant
disappearance of the Rac2 signal from the cytosol, as
shown in Fig. 1A. The effect of this hormone on OK2
production by human neutrophils was also examined,
and the values found were 0.043G0.009 (in control cells
without additions), 0.165G0.022 (with 1 nM Ang II),
0.897G0.103 (with 10 nM Ang II) and 1.123G0.236
(with 100 nM Ang II) relative units of chemi-
luminescence. It was thus observed that Ang II elicited
OK2 synthesis in a dose-dependent manner, confirming
our previous report (El Bekay et al. 2003). Short-time
kinetic experiments (Fig. 1B) revealed that an effective
Ang II-dependent translocation of Rac2 from the
cytosol to the plasma membrane took place as soon as
within 1 min of incubation with the hormone, with
maximal membrane levels being reached after 5 min of
treatment. Rac2 translocation in Ang II-stimulated
neutrophils was prevented by a 10 ng/ml dose of
eprosartan (Fig. 1C), an inhibitor of the AT1 Ang II
receptor (Brooks et al. 1999), indicating a specific role
for this receptor in Ang II-induced Rac2 translocation
in human neutrophils. In control experiments, the
same effects were obtained when the chemoattractant
fMLP at 100 nM substituted for Ang II (data not
shown). The membrane levels of p22phox at the
membrane, in keeping with it being an integral
membrane protein (Mankelow & Henderson 2001),
were similar in both resting and Ang II-stimulated
neutrophils (Fig. 1A–C). We further investigated the
effect of Ang II on the subcellular localization of Rac2
using immunofluorescence microscopy. As shown in
Fig. 1D, this protein was primarily cytoplasmic in
unstimulated cells (Fig. 1a and b), but was found
predominantly located at the plasma membrane upon
incubation of neutrophils with 10 nM Ang II for 10 min
(Fig. 1c and d). These results corroborated that Ang II
promotes the translocation of Rac2 to the cell
membrane in human neutrophils.Involvement of calcineurin, MAP kinases and PI3K in
Ang II-dependent Rac2 translocation to the plasma
membrane in human neutrophils
We have recently shown that Ang II induces an
increase of both de novo synthesis and activity of CaN
in human neutrophils (El Bekay et al. 2003). In order
to determine whether inhibition of CaN activity
affected Rac2 translocation to the plasma membrane,
we pretreated neutrophils with CsA for 1 h. Figure 2A
and B shows that CsA at a 0.3 mg/ml concentration was
sufficient to suppress Rac2 translocation induced by
Ang II in these cells indirectly suggesting an involve-
ment of CaN in Ang II-dependent Rac2 mobilization to
the plasma membrane in human neutrophils.www.endocrinology-journals.org
Figure 6 Clostridium difficile toxin A inhibits Ca2C-dependent Rac2 activation in Ang II-stimulated human neutrophils. Neutrophils
(107 cells/ml) were preincubated at 37 8C with 10 ng/ml toxin A from C. difficile (Tox A) for 30 min (A), or with 1 mM thapsigargin (Tg) plus
0.1 mM EGTA for 5 min (B), and then they were treated or not with 10 nM Ang II for further 10 min. Thereafter, Rac2 plasma membrane
levels were analysed by immunoblotting, together with p22phox levels as a loading control. Each blot is representative of a set of four
experiments yielding similar results, and values given within parentheses correspond to Rac2membrane levels normalized to those found
in the absence of treatments (meanGS.E.M. from three separate experiments). Statistically significant *P!0.01. In separate experiments,
neutrophils were preincubated with or without 5–10 ng/ml Tox A for 30 min, and then treated or not with 10 nM Ang II for 5 h at 37 8C, and
CaN phosphatase activity was measured in cell extracts (C), or CaN protein levels were analysed by immunoblotting (D). Arrowheads
point to CaN A and B subunits (59 and 19 kDa respectively) in panel D. Finally, Fura2-loaded neutrophils were preincubated with different
concentrations of Tox A and intracellular Ca2C levels reached upon addition of 10 nM Ang II (arrow) were recorded (E). Each panel is
representative of a set of three separate experiments yielding similar results.
Ang II activate Rac2 GTPase . R EL BEKAY, G ALBA and others 357In addition, we have reported that Ang II elicits
phosphorylation of both p38MAPK and ERK1/2 in
human neutrophils, and that inhibition of these two
MAPKs by SB203580 and PD098059 respectively, preventswww.endocrinology-journals.orgAng II-stimulated ROS=OK2 production as well as translo-
cation of the p47phox and p67phox NADPH oxidase
subunits to the plasma membrane (El Bekay et al. 2003).
As shown in Fig. 3A, we now found that these twoJournal of Molecular Endocrinology (2007) 39, 351–363
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membrane translocation in Ang II-stimulated neutro-
phils. In a similar manner, the Ang II-promoted Rac2
translocation was effectively hindered by SP600125, an
inhibitor of JNK1/2, in human neutrophils (Fig. 3B).
It has recently been reported that Rac2 becomes
activated by fMLP by a PI3K-mediated mechanism in
human neutrophils (Akasaki et al. 1999). Since we have
previously shown that wortmannin, a pharmacological
PI3K inhibitor, inhibits ROS production by these cells
(El Bekay et al. 2003), we set to investigate the possible
involvement of PI3K in Ang II-induced Rac2 mobili-
zation. As shown in Fig. 3C, wortmannin blocked partially
Rac2 translocation at a 10 nM dose, and totally at 100 nM.
These data indicated that PI3K activity is also required for
translocation of Rac2 from the cytosol to the plasma
membrane in Ang II-stimulated human neutrophils.Ang II promoted Rac2 GTP-binding activity in
human neutrophils
In order to determine whether Ang II-induced Rac2
membrane translocation correlated with an increase in
Rac2 GTP-binding activity, a PAK-1 PBD pull-down assay
was carried out which was based on the property
exhibited by PAK-1/3 Ser/Thr kinases of becoming
stimulated upon their binding of active Rac GTPases
(Bokoch 2003). Figure 4A shows that the treatment of
human neutrophils with Ang II at 10 nM resulted in an
up-regulation of Rac2 GTP binding by up to 40-fold.
This enhancement was inhibited by eprosartan, indi-
cating that this phenomenon depended on Ang II
binding to AT1 receptors. Rac2 GTP-binding activity
was also increased upon cell stimulation with 100 nM
fMLP (Fig. 4A), as previously described in human
neutrophils (Akasaki et al. 1999). As a control, when
human neutrophil lysates were incubated with GTPgS,
Rac2 was found to massively bind to PAK-1 PBD,
whereas no such association was detected when lysates
were incubated with GDP (Fig. 4A). We also examined
the effect of p38MAPK and ERK1/2 inhibitors on Rac2
GTP binding in Ang II-stimulated neutrophils. Figure 4B
shows that both SB203580 and PD098059 hindered
GTP binding by Rac2 suggesting an implication of both
MAPKs in the signalling pathways modulating the Ang
II-elicited targeting of Rac2 to the plasma membrane.Figure 7 Clostridium difficile toxin A inhibits angiotensin II-dependent
Neutrophils (107 cells/ml) were preincubated for 7 h at 37 8C in KR-HE
indicated concentrations of clostridial toxin A (Tox A) and thereafter fo
phosphorylated p38MAPK (A), ERK1/2 and JNK1/2 (B) were then ana
was substituted by 100 mM NSC23766 and, after incubation with 10–1
phosphorylated and total p38MAPK and JNK1/2 (C) or ERK1/2 (D) wer
of four experiments yielding similar results, and values given within pa
normalized to those found in the absence of treatments (meanGS.E.M
comparison between unstimulated control and Ang II stimulated *P!0
inhibitors treated, CP!0.01.
www.endocrinology-journals.orgBesides, Rac2 GTP-binding activity was totally inhibited by
the PI3K inhibitor, wortmannin (Fig. 4C). As expected,
Rac2 GTP-binding activity was also abolished in the
presence of toxin A from C. difficile, confirming previous
data (Aktories et al. 2000).Ang II induced MAP kinases activation through
calcineurin in human neutrophils
In order to determine whether Rac2 translocation to the
plasma membrane elicited by Ang II was mediated by
signalling molecules other than MAPKs, the effect of
pretreatment with the CaN inhibitor, CsA, prior to Ang II
addition was assessed. We found that CsA at 1 mg/ml
suppressed Rac2 GTP-binding activity induced by Ang II in
human neutrophils, as revealed by its hindering of Rac2
GTP-binding activity (Fig. 4D). In addition, given that CsA
was also able to inhibit Rac2 translocation to the plasma
membrane (Fig. 2), and that crosstalk between CaN and
MAPKshasbeenreported inmyocytes (Lim et al. 2001) and
in neutrophils (El Bekay et al. 2003), the inhibitory effect of
CsA could be indirectly exerted through MAPK inhibition.
In order to test this possibility, we examined the effect of
CsA on Ang II-induced p38MAPK, ERK1/2 and JNK1/2
activation in human neutrophils. As shown in Fig. 5A
and B, CsA prevented the phosphorylation, and hence the
activation, of these three MAPKs by Ang II. These results
allowed us to infer that CaN has an implication in both
Rac2 and MAPK activation elicited by Ang II in human
neutrophils.Ang II-dependent Rac2 GTPase activity regulated
ROS=OK2 production, cytosolic Ca
2C release and
calcineurin activity
The treatment of cells with C. difficile toxin A
(5–10 ng/ml), an inhibitor of the GTPase activity of
GTP-binding proteins such as Rac, Rho and Cdc42
(Aktories et al. 2000, Voth & Ballard 2005), was found to
reduce OK2 and total ROS release by w81 and 97%
respectively, in Ang II-stimulated human neutrophils when
compared with untreated cells (Table 1), this indicating
that GTPase activity plays a pivotal role in NADPH oxidase
activation by Ang II in human neutrophils. In parallel, C.
difficile toxin A was found to abolish Ang II-dependent Rac2
translocation to the plasma membrane (Fig. 6A). Since itp38MAPK, ERK1/2 and JNK1/2 activation in human neutrophils.
PES without additions. Then they were treated for 30 min with the
r 10 min with 10 nM Ang II, where indicated. The levels of
lysed by immunoblotting. In a separate set of experiments, Tox A
00 nM Ang II or 100 nM PMA for 10 min, the levels of
e analysed by immunoblotting. Each blot is representative of a set
rentheses correspond to levels of phosphorylated MAPKs
. from three separate experiments). Statistically significant,
.01 and comparison between Ang II stimulated and Ang II plus
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Ca2C in human neutrophils (El Bekay et al. 2003), we set to
test whether Ca2C signalling was involved in Ang
II-dependent Rac2 activation. With this aim, neutrophils
were pretreated simultaneously with thapsigargin, in order
to deplete intracellular Ca2C stores, and with EGTA to
chelate extracellular Ca2C, and then the cells were
activated by the addition of Ang II. Figure 6B shows that
under these conditions Ang II-elicited Rac2 mobilization
became drastically inhibited, indicating that cytosolic Ca2C
elevation is crucial for Rac2 translocation to the plasma
membrane.C. difficile toxin A treatment also inhibited CaN
activity (Fig. 6C), but did not affect the de novo synthesis of
CaN induced by Ang II (Fig. 6D). Conversely, we also
assessed whether elevation of intracellular Ca2C required
activation of Rac2 GTPase. As shown in Fig. 6E, when
increasing doses of C. difficile toxin A were added to cells
prior to Ang II stimulation, the Ca2C signal was hindered,
suggesting that the Ca2C mobilization elicited by Ang II
in human neutrophils depends, at least in part, on the
activation of Rac2. In this context, Rac2 has also been
shown to participate in actin polymerization and cytoskele-
ton rearrangement. Present observations on the inhibition
on Ca2Cmobilization could be thus linked to the disruption
of the actin cytoskeleton organization induced by several
toxins, as previously observed (Bozem et al. 2000).Ang II induced p38MAPK, ERK1/2 and JNK1/2
activation through Rac2 GTPase activity
Subsequent experiments were designed to examine
whether the inhibition of Rac2 affected MAPK acti-
vation in Ang II-stimulated neutrophils. Figure 7A and B
shows that C. difficile toxin A at a 5–10 ng/ml dose
efficiently prevented Ang II-dependent p38MAPK,
ERK1/2 and JNK1/2 activation. In order to gain insight
on the specificity of this inhibitory effect, we also used
a chemical compound, NSC23766, identified as a
Rac-specific small-molecule inhibitor (Gao et al. 2004).
NSC23766 exhibited an inhibitory effect on the
phosphorylation of p38MAPK, JNK1/2 and ERK1/2
similar to that exerted by C. difficile toxin A (Fig. 7C
and D). These results thus led support to the idea
that the signalling pathways mediated by these three
MAPKs are involved in Rac2 targeting to the cell
membrane.Discussion
Recent clinical studies have shown that Ang II is a key
player in several pathological processes, including
hypertension and atherosclerosis (Ross 1999). We
have demonstrated that Ang II activates human
neutrophils through the induction of OK2 =ROSJournal of Molecular Endocrinology (2007) 39, 351–363production, consistently with the translocation to the
cell membrane of the cytosolic components of NADPH
oxidase, p47phox and p67phox (El Bekay et al. 2003).
Despite Rac2 having been reported as participating in a
wide array of signalling pathways in neutrophils and
other cells (Roberts et al. 1999, Yang et al. 2000), its role
in the stimulation of these cells by Ang II has yet not
been addressed. In the present work, we report for the
first time the ability of Ang II to induce translocation of
Rac2 from the cytosol to the plasma membrane, and to
enhance its GTP-binding activity in a dose-dependent
manner via AT1 receptors in human neutrophils.
Previous and present data also indicate that transloca-
tion to the plasma membrane of the p47phox and
p67phox subunits of NADPH oxidase and of Rac2 occur
in parallel in Ang II-activated human neutrophils. In
this context, it has been reported that Rac2 mobil-
ization to the cell membrane is diminished in p47phox-
deficient neutrophils from chronic granulomatous
disease (CGD) patients (El Benna et al. 1994). However,
Rac2 translocation is not affected in CGD neutrophils
lacking p67phox (Dusi et al. 1995a). In contrast, other
authors have shown that Rac2 is able to translocate
independently of other cytosolic factors, and to migrate
to the cell membrane in the absence of both p67phox
and p47phox in human neutrophils (Heyworth et al.
1994, Dusi et al. 1995b).
Also, we have observed that both Ang II-dependent
Rac2 translocation and its GTPase activity increase were
abrogated by CsA, a CaN inhibitor and immunosup-
pressant, and that this compound prevented p38MAPK,
ERK1/2 and JNK1/2 activation by Ang II. These data
thus underscore a pivotal role of CaN both in Rac2
translocation and the activation of these three MAPKs
in Ang II-stimulated human neutrophils. Other authors
have also shown that Rac is an upstream mediator of
PAK-1 and JNK1/2 activation during Ang II signalling
in vascular smooth muscle cells (Schmitz et al. 2001,
Woolfolk et al. 2005). However, the crosstalk between
Rac2 and MAPKs in Ang II-stimulated human neutro-
phils had not been hitherto investigated. Here, we
describe that both Rac2 membrane translocation and
enhanced GTP-binding activity elicited by Ang II were
blocked by SB203580 and PD098059, two compounds
acting as inhibitors of p38MAPK and ERK1/2 respec-
tively. Rac2 mobilization was also shown to be prevented
by the JNK1/2 inhibitor, SP600125. Taken together, the
present results lead us to infer that these MAPKs are
likely to play a relevant role in the targeting of Rac2,
p47phox and p67phox to the plasma membrane. We have
also observed that both Ang II-dependent Rac2
enhanced GTP-binding activity and translocation to
plasma membrane in these cells were inhibited by
wortmannin, a PI3K inhibitor. This indicates that
PI3K is also likely to participate in Rac2 activation
promoted by Ang II, in agreement with previous studieswww.endocrinology-journals.org
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activated by fMLP in a PI3K-dependent manner
(Akasaki et al. 1999).
C. difficile produces two toxins, which cause notable
pathological disorders. Both, toxins A and B, trans-
locate to the cytosol of target cells and inactivate small
GTP-binding proteins, which include Rho, Rac and
Cdc42. Inactivation of these substrates occurs through
monoglycosylation of a single reactive threonine, which
lies within their effector-binding loop and coordinates a
divalent cation critical for GTP binding. By glycosylat-
ing small GTPases, toxins A and B cause actin
condensation and cell rounding, which is followed by
cell death (Just et al. 1995, Voth & Ballard 2005). Our
data illustrate that toxin A dramatically inhibited both
OK2 =ROS and ROS production and p38MAPK, ERK1/2
and JNK1/2 phosphorylation, in agreement with the
pivotal role assigned to Rac2 in NADPH oxidase
activation (Kim & Dinauer 2001, 2006) and in MAPK
phosphorylation (Yu et al. 2001). These results
indicate that Rac2 is necessary both for optimal
activity of the assembled oxidase complex towards
ROS production and MAPK-mediated signalling
elicited by Ang II.
In order to obtain a more specific inhibitory effect on
Rac2 activity, we also tested a chemical compound,
NSC23766, identified as a Rac-specific small-molecule
inhibitor (Gao et al. 2004). We have observed that this
molecule evoked an inhibition of the Ang II-dependent
phosphorylation of both p38MAPK, ERK1/2 and
JNK1/2 and similar to that provoked by toxin A.
These data are in agreement with a previous study
showing that T cells from Rac2-deficient mice exhibit a
decreased phosphorylation of p38MAPK and ERK1/2,
in parallel to a reduced antigen-induced Ca2C efflux
(Yu et al. 2001).
In the search of other intracellular signalling events
related to Rac2, increased intracellular Ca2C seems
sufficient to induce Rac2 activation in several epithelial
cell lines (Price et al. 2003). However, fMLP-induced
Rac2 activation is independent of intracellular Ca2C in
human neutrophils (Geijsen et al. 1999). From our data,
a mutual interdependence between Rac2 and Ca2C
mobilization seems operative, since clostridial toxin A
inhibited Ang II-stimulated cytosolic Ca2C elevation
and, conversely, Ang II-elicited Rac2 activation was
blocked upon the chelation of intra- and extracellular
Ca2C using thapsigargin plus EGTA. These findings
thus strongly suggest that cytosolic Ca2C increase
induced by Ang II is necessary for Rac2 activation.
Our results are also consistent with recently published
data showing that Ang II induces CaN activation in
human neutrophils (El Bekay et al. 2003), and suggest
the existence of a pathway linking Ca2C/CaN and
MAPK signalling pathways, as it occurs in cardiac
myocytes (Lim et al. 2001). This notion is furtherwww.endocrinology-journals.orgsupported by our previous observations that Ang II
enhances CaN expression and NF-kB DNA-binding
activity in human neutrophils, which constitute two
crucial intracellular signalling events (El Bekay et al.
2003). It has also been shown that Ang II modulates the
cellular immune response through a CaN-dependent
pathway (Nataraj et al. 1999). Interestingly, CaN has
been shown to synergize with protein kinase C (PKC)
to activate Rac in T cells (Werlen et al. 1998), and to
engage in crosstalk with PKC and MAPK activation in
transducing the Ang II stimulus in cardiomyocytes
(Murat et al. 2000). Both proteins, Rac2 and PKC, are
constituents of the machinery responsible for the
activation of NADPH oxidase (Kwong et al. 1993,
Bokoch & Knaus 1994) and are thus amenable to
participate in Ang II-dependent signal transduction
pathways. Also, it has been reported that the rapid CsA-
induced depression of the respiratory burst in neu-
trophils stimulated by fMLP is due to a primary
reduction of Ca2C signalling (Nguyen et al. 1998).
In this context, present observations illustrate for the
first time the prevention of Ang II-dependent intra-
cellular Ca2C elevation through Rac2 inhibition (by
C. difficile toxin A), with simultaneous decrease of CaN
activity, events which are consistent with the view that
Rac2 activation is coupled to the elicitation of
intracellular oxidative stress by Ang II in human
neutrophils.
Finally, our results also illustrate that MAPK acti-
vation and both Rac2 translocation to the plasma
membrane and GTP-binding activity in Ang II-stimu-
lated neutrophils are mutually regulated processes,
given that specific pharmacological inhibitors acting on
either the MAPK or the Rac2 pathway reciprocally
abrogated activation of the other. Although the precise
hierarchy is difficult to determine, the complex
response elicited by Ang II in neutrophils suggests
that the presumptive crosstalk between Rac2 and MAPK
activation mechanisms is probably dependent on the
participation of other putative signalling pathways, such
as those mediated by PI3K, Ca2C elevation or CaN
activation.
Summarizing, present data provide a framework
linking Rac2 activation to the signalling pathways
switched on by Ang II in human neutrophils, and allow
to extend our previous observations on the crosstalk
between NADPH oxidase activation and other signalling
pathways which become activated by phosphorylation.
Elucidation of the specific mechanisms whereby Rac
GTPases act to modulate the respiratory burst in
neutrophils should provide insight on the precise role
of the various signalling pathways involved in inflam-
matory processes, and in turn be useful to design novel
therapies targeting the chronic inflammation of vessel
walls typical of atherosclerosis and hypertension.Journal of Molecular Endocrinology (2007) 39, 351–363
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